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Abstract. We introduce a wide and deep neural network for prediction of
progression from patients with mild cognitive impairment to Alzheimer’s
disease. Information from anatomical shape and tabular clinical data
(demographics, biomarkers) are fused in a single neural network. The
network is invariant to shape transformations and avoids the need to
identify point correspondences between shapes. To account for right
censored time-to-event data, i.e., when it is only known that a patient
did not develop Alzheimer’s disease up to a particular time point, we
employ a loss commonly used in survival analysis. Our network is trained
end-to-end to combine information from a patient’s hippocampus shape
and clinical biomarkers. Our experiments on data from the Alzheimer’s
Disease Neuroimaging Initiative demonstrate that our proposed model is
able to learn a shape descriptor that augments clinical biomarkers and
outperforms a deep neural network on shape alone and a linear model on
common clinical biomarkers.
1 Introduction
Alzheimer’s disease (AD) is a neurodegenarative disorder and the most common
form of dementia diagnosed in people over 65 years of age. Initially, patients
suffer from short memory loss, until progressive deterioration eventually requires
patients to be completely dependent upon caregivers due to severe impairment
of cognitive and motor abilities [38,45,1]. Mild cognitive impairment (MCI) is
a pre-dementia stage which is characterized by clinically significant cognitive
decline, but without impairing daily live [41,29]. Although subjects with MCI are
at an increased risk of developing dementia due to AD, a significant portion of
patients with MCI remain stable and do not progress [41]. The pathophysiological
processes of this transition are complex and not fully understood, but previous
studies showed that changes in certain biomarkers precede the onset of cognitive
symptoms by many years [25]. Important biomarkers include brain atrophy mea-
sured by magnetic resonance images (MRI), levels of cortical amyloid deposition
obtained from cerebrospinal fluid (CSF), and glucose uptake of neurons measured
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by fluorodeoxyglucose positron emission tomography (FDG-PET) (see [44] for a
detailed overview). To stop or slow down the progression to dementia, it is vital
to identify those patients that are at an increased risk for rapid progression from
MCI to AD. In particular, several previous studies have established strong mor-
phological changes in the hippocampus associated to the progression of dementia
[18,19,51,50,20].
We study progression to Alzheimer’s disease by explicitly modelling the timing
of this transition and by considering the finite follow-up time and drop-out of
patients in clinical studies using techniques from survival analysis (also called
time-to-event analysis). Survival analysis differs from traditional machine learning
in the fact that parts of the training data can only be partially observed – they
are censored. If a patient withdraws from the study, is lost to follow-up, or did
not develop AD during the study period, the patient’s time of progression is right
censored, i.e., it is unknown whether the patient has or has not progressed after
the study ended. Only if a patient develops AD during the study period, one can
record the exact time of this event – it is uncensored.
In this paper, we propose for the first time a wide and deep neural network
for survival analysis that learns to identify patients at high risk of progressing
to AD by fusing information from 3D hippocampus shape and tabular clinical
data. To the best of our knowledge, no one has previously attempted to learn a
deep survival model on 3D anatomical shape representations in an end-to-end
fashion. In our experiments on data from the Alzheimer’s Disease Neuroimaging
Initiative, we demonstrate by fusing information we can more accurately predict
AD converters than a baseline deep network on shapes and a Cox’s proportional
hazards model on clinical data.
2 Related Work
Most previous work formulates progression analysis from MCI to AD as a classifi-
cation problem within a fixed time horizon such as 3 years (see e.g. [4,9,11,40,48]).
The major downside of this approach is that such a model cannot generalize
to other time spans, and that censored conversion times are ignored during
training. Instead, it is statistically more appropriate to explicitly incorporate
censored event times using methods from survival analysis. Several authors
used survival analysis techniques by combining information from various modali-
ties such as structural MRI, FDG-PET, genetics, and neuropsychological tests
[3,12,13,14,15,27,31,34,46,49,51,53]. All of these approaches compute features
from high-dimensional imaging data in a pre-processing step, before training a
linear survival model. They differ with respect to the type and extend of computed
features, which range from volume measurements of a few brain regions [15] to
voxel-based analysis [49]. In addition, we note that extensive prior work aims to
identify healthy controls, patients with MCI, and patients with AD by casting
it as a three-way classification problem and using multi-view machine learning
techniques; we refer interested readers to the review in [36].
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In contrast, this work focuses on multi-view learning to predict progression
from MCI to AD, which has been formulated as a classification problem within a
fixed time period in [35,47,52,54]. [52] propose to use sparsity-inducing penalties
to combine features extracted from MRI and PET images with CSF measurements
and neuropsychological tests. MCI to AD conversion within 2 years was studied
in [35]. They propose to learn from features extracted from MRI and FDG-PET,
and CSF measurements by view-aligned hypergraph learning. The approach
in [47] uses stability-weighted low-rank matrix completion to impute missing
values in MRI and PET features, and neuropsychological tests. They consider
right censored conversion times as missing values and try to impute the actual
(unobserved) time of conversion via matrix completion. In [54], the authors
propose a missing-data-aware approach to learn from MRI, PET, and genetics by
learning a common and multiple modality-specific latent feature representations.
To the best or our knowledge, the only previous work that employed multi-view
learning for survival analysis was presented in [42] for predicting adverse events
in cancer and heart disease.
Using neural networks for survival analysis originated in the late 1990s in
the work of [2,5,16,33], who studied relatively simple networks with one hidden
layer applied to tabular data. The first deep survival model was proposed in [26]
and builds on the loss proposed in [16]. The only previous work that investigated
deep learning for MCI to AD conversion from multi-modal data is [30,37]. Both
approaches consider a classification problem within a fixed time frame, which
ignores censoring of conversion times. In addition, the features in [30] were
pre-computed from MRI and not learned end-to-end. In [37], a deep network is
proposed that learns from 3D patches of MRI and FDG-PET at multiple scales.
Finally, [20] proposed a deep neural network operating on point clouds of
multiple neuroanatomical shapes. They study diagnosis of MCI and AD patients
rather than progression, and do not consider demographics or clinical biomarkers
in their model.
3 Methods
We present a wide and deep neural network for learning from right censored
time-to-event data (see fig. 1). Our model takes a point cloud representation of
an anatomical shape and tabular data as input. The deep part of the network is
a PointNet [43] that learns features describing the 3D geometric structure of the
left hippocampus. The wide part of the network takes demographics and clinical
biomarkers and their interactions. The network is trained to fuse both types of
information in and end-to-end fashion using a survival analysis loss appropriate
for right censored event times. First, we are going to describe PointNet, which
constitutes the deep part of the network, before showing how it can be integrated
with tabular clinical data for survival analysis.
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3.1 Learning from Anatomical Shape
We represent anatomical shapes as point clouds that represent a 3D geometric
structure as a set of coordinates. Point clouds avoid the combinatorial irregularities
and complexities of meshes, and thus are easier to learn from. However, the
network needs to be constructed in a way to consider that a point cloud is just
an unordered set of points that is invariant to permutations of its members. To
this end, we employ PointNet [43], which is illustrated in fig. 1 and described in
more detail below.
The i-th point cloud Pi is represented by a set of K 3D coordinates Pi =
{pi1 , . . . ,piK} with pik ∈ R3 being the x, y, and z coordinates. To be invariant
to permutations of the input set, the symmetric max pooling operator across
all embedding vectors of points is used. We first pass each individual coordinate
vector through a multilayer perceptron MLPpoint with shared weights among all
points, thus projecting each 3D point to a higher dimensional representation.
These representations are aggregated using the max pooling operator across all
points, which ensures that our downstream survival analysis task is invariant to
permutation:
POINTNET(Pi) = MAXPOOL (MLPpoints(pi1), . . . ,MLPpoints(piK )) . (1)
MLPpoint is a three-layer network with 64, 128, and 400 dimensional outputs,
respectively, with rectified linear units (ReLU) and batch normalization [23].
Hence, we extract 400 features that globally describe the input anatomical shape.
In order to make our network invariant to rotation of the input point cloud,
we use an affine transformation network that outputs a rotation matrix T ∈ R3×3
which is multiplied by the raw 3D coordinates of input points. This transforma-
tion is learned in a data-dependent manner by using an additional POINTNET
network that learns to predict the optimal T for each individual point cloud. The
global feature vector computed by POINTNET is fed to three fully-connected
layers with 200, 100, and 9 units, ReLU activation function and batch normaliza-
tion, respectively. Finally, we modify the vanilla PointNet in (3) by transforming
individual points by the output of the transformation network:
TRANSFORM(Pi) = MAXPOOL (MLPpoints(pi1), . . . ,MLPpoints(piK )) ,
ϕik = TRANSFORM(Pi)pik ,
POINTNET(Pi) = MAXPOOL (MLPpoints(ϕi1), . . . ,MLPpoints(ϕiK )) .
(2)
3.2 Wide and Deep Neural Network
After obtaining a global latent representation of an anatomical shape, we can
further learn high-level descriptors of point clouds by feeding the output of the
max pooling operation to an MLP. In addition, we can leverage routine clinical
patient information to predict progression to Alzheimer’s disease. Typically, such
information consists of feature vectors that are either dense (e.g. biomarker
concentrations), or sparse (e.g. one-hot encoded genetic alterations). Compared
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Fig. 1. Wide and Deep PointNet Architecture. The network takes a point cloud repre-
sentation P of the left hippocampus with K points, applies a transformation, and then
aggregates point features by max pooling. The global feature vector is processed by
a global MLP outputting a 100-dimensional latent representation that is fused with
tabular clinical data using a linear model.
to individual points in a point cloud, clinical information already contains rich
information for which we do not need to learn a highly abstract latent represen-
tation. In fact, most clinical research relies on linear models, which allow for easy
interpretation of individual feature’s contribution to the overall prediction.
Here, we jointly train a linear model on clinical information with a deep
PointNet on anatomical shapes using a wide and deep architecture [8]. While
the deep component learns a complex latent representation of anatomical shape,
the linear component models known clinical variables x ∈ Rd associated with
Alzheimer’s disease. In particular, we can easily incorporate gene-gene (epistasis)
and gene–environment interactions by using a cross-product transformation
φ(x) [8]. Thus, the final patient-level latent representation is given by
µ(xi,Pi) = w>wideCONCAT(xi, φ(xi))
+w>deepMLPglobal(POINTNET(Pi)), (3)
where CONCAT denotes vector concatenation, POINTNET is the global feature
vector from (2), MLPglobal is a three-layer MLP with 200, 100, and 100 units,
ReLU activation and batch normalization, and wwide and wdeep are weights to
be learned.
3.3 Survival Analysis
Our overall objective is to predict progression from mild cognitive impairment to
Alzheimer’s disease from right censored time-to-event data, which demands for
proper training algorithms that take this unique characteristic into account. More
formally, we denote by ti > 0 the time of an event (Alzheimer’s disease), and
ci > 0 the time of censoring of the i-th patient. Due to right censoring, it is only
possible to observe yi = min(ti, ci) and δi = I(ti ≤ ci) for every patient, with I(·)
being the indicator function and ci =∞ for uncensored records. Hence, training
our survival model is based on a dataset comprising quadruplets (Pi,xi, yi, δi)
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for i = 1, . . . , n. After training, the survival model ought to predict a risk score
of experiencing an event based on a point cloud and a set of clinical features. As
loss function, we employ the loss proposed in [16], which is an extension of Cox’s
proportional hazards model [10] to neural networks. Let Θ denote the set of all
parameters of the wide and deep neural network (3), then we want to solve
argmin
Θ
n∑
i=1
δi
µ(xi,Pi |Θ)− log
∑
j∈Ri
exp(µ(xj ,Pi |Θ))
 , (4)
where Ri = {j | yj ≥ ti} denotes the risk set, i.e., the set of patients who were
still free of Alzheimer’s disease shortly before time point ti.
4 Experiments
4.1 Data
In our experiments, we are using data from the Alzheimer’s Disease Neuroimaging
Initiative (ADNI) [24]. ADNI was launched in 2003 as a public-private partnership
with the primary goal to test whether longitudinal MRI and PET imaging
combined with other biomarkers, clinical and neuropsychological assessments
to measure the progression of MCI and early AD. For up-to-date information,
see www.adni-info.org. We selected 397 subjects with MCI at baseline and
at least one follow-up visit. Magnetic resonance images of all subjects were
processed with FreeSurfer [17] to obtain segmentations, which were subsequently
pre-processed using the grooming operations included in ShapeWorks [7] to obtain
smooth hippocampi surfaces. We used left hippocampus shapes represented as
point clouds comprised of 1024 points. For tabular clinical data, we used age,
gender, education, CSF, FDG-PET, and AV45-PET. CSF measurements included
levels of beta amyloid 42 peptides (Aβ42), total tau protein (T-tau), and Tau
phosphorylated at threonine 181 (p-Tau181). We augment age to account for
non-linear effects by using a natural B-spline expansion with four degrees of
freedom and an interaction term between age and gender [22]. Education, which
is a categorical variable, was encoded using orthogonal polynomial coding. In
addition, we considered left hippocampus volume (normalized by intra-cranial
volume) as estimated by FreeSurfer [17] from MRI scans of the brain.
4.2 Model Training
We trained our deep and wide network using Adam [28] for 120 epochs with weight
decay. We tuned hyper-parameters (size of PointNet’s global feature vector, size of
wdeep, weight decay, learning rate schedule, β1 of Adam) using Bayesian black-box
optimization by computing the model’s performance on the validation set [32].
Data is randomly split into three parts: 80% for training, 10% for validation,
and 10% for testing. We repeated this process 10 times with different splits. The
performance of all methods was estimated by Harrell’s concordance index (c
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index), which is identical to the area under the receiver operating characteristics
curve if the outcome is binary and no censoring is present [21]. As baseline model,
we selected a linear Cox’s proportional hazards model (CoxPH) [10] trained on
tabular clinical data. The baseline model was trained once on tabular clinical
data only (see above), and once with the volume of left hippocampus included as
additional feature. We note that CoxPH and our model optimize the same loss
during training. Therefore, differences in performance stem from the ability of
our model to directly incorporate 3D anatomical shape information.
5 Results
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Fig. 2. Performance of individual models across ten random splits of the data. w/
Volume: tabular data includes left hippocampus volume. w/o Volume: tabular data
does not include left hippocampus volume.
The performance of our deep and wide network and baseline models is
summarized in fig. 2. It shows that tabular clinical makers with a median c index
of 0.750 are already strong predictors of conversion from MCI to AD. When
including hippocampus volume as additional feature, the median c index increased
to 0.803. Using a deep PointNet solely using hippocampus shape and ignoring
any clinical variables resulted in a c index of 0.534. Our deep and wide network
achieved a median c index of 0.780 without hippocampus volume, and 0.809 with
hippocampus volume. The latter is the model with highest median c index and
outperforms the linear model with hippocampus volume on 6 of 10 splits. This
shows that when jointly learning a deep PointNet, it is able to learn a powerful
global descriptor of hippocampus shape that augments clinical features for MCI-
to-AD progression. Moreover, our results confirm that hippocampus volume is a
useful independent predictor that cannot be fully captured by anatomical shape
alone, as described previously [50].
We can also compare the coefficients of the linear models with the linear part
of our wide and deep neural network. The coefficients can be directly interpreted
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Fig. 3. Comparison of coefficients associated with tabular clinical features. Additional
eight orthogonal polynomial encodings of education have been omitted from this plot.
w/ Volume: tabular data includes left hippocampus volume. w/o Volume: tabular data
does not include left hippocampus volume.
in terms of log-hazard ratio, which is a measure of effect a variable has on
survival, similar to log-odds ratio in logistic regression. The coefficients across all
folds are depicted in fig. 3. All models agree with respect to which features are
contributing to increased/decreased hazard of AD, as indicated by the coefficients’
sign, except for p-Tau. The linear model without hippocampus volume associated
higher p-Tau levels with a decrease in hazard (on average) compared to the other
models, which is surprising because hyperphosphorylation of tau is a marker
for AD [6]. The most important clinical features (in terms of magnitude) are
gender and education for both linear models, but have only minor importance
for the deep and wide network. Similar behavior can be observed for age-gender
interactions. In addition, increased hippocampus volume has a relatively high
importance and is associated with a decreased hazard of AD. It is ranked third
for the deep and wide network and eleven for the linear model. FDG-PET has
the biggest effect for the wide and deep network and is also among the top 4
features for the linear models. From a clinical perspective, this result is reassuring
as reduction of metabolic activity in cortical regions has been associated with
AD [39]. Finally, we note that the variability of coefficients across splits is smaller
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for the deep and wide neural network compared to the linear model. We believe
this is an effect of using weight decay during optimization, which penalizes large
coefficients.
6 Conclusion
We proposed a wide and deep neural network that fuses 3D anatomical shape
and tabular clinical variables for the prediction of MCI-to-AD conversion. We
trained a model end-to-end using a survival loss that properly accounts for right
censored time of conversion. Our experiments demonstrate that the proposed
architecture is able to learn a global shape descriptor that augments clinical
variables and leads to improved prediction performance.
Acknowledgements This research was partially supported by the Bavarian
State Ministry of Education, Science and the Arts in the framework of the Centre
Digitisation.Bavaria (ZD.B). We gratefully acknowledge the support of NVIDIA
Corporation with the donation of the Quadro P6000 GPU used for this research.
References
1. Albert, M.S., DeKosky, S.T., Dickson, D., Dubois, B., Feldman, H.H., Fox, N.C.,
Gamst, A., Holtzman, D.M., et al.: The diagnosis of mild cognitive impairment
due to Alzheimer’s disease: recommendations from the National Institute on Aging-
Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.
Alzheimer’s & dementia : the journal of the Alzheimer’s Association 7, 270–279
(2011)
2. Bakker, B., Heskes, T.: A neural-Bayesian approach to survival analysis. In: 9th
Int. Conf. Artif. Neural Networks (ICANN). pp. 832–837 (1999)
3. Barnes, D.E., Cenzer, I.S., Yaffe, K., Ritchie, C.S., Lee, S.J.: A point-based tool to
predict conversion from mild cognitive impairment to probable Alzheimer’s disease.
Alzheimer’s & Dementia 10(6), 646–655 (2014)
4. Beheshti, I., Demirel, H., Matsuda, H., Alzheimer’s Disease Neuroimaging Initiative:
Classification of Alzheimer’s disease and prediction of mild cognitive impairment-
to-Alzheimer’s conversion from structural magnetic resource imaging using feature
ranking and a genetic algorithm. Computers in biology and medicine 83, 109–119
(2017)
5. Biganzoli, E., Boracchi, P., Mariani, L., Marubini, E.: Feed forward neural networks
for the analysis of censored survival data: a partial logistic regression approach.
Stat. Med. 17(10), 1169–1186 (1998)
6. Blennow, K., Vanmechelen, E., Hampel, H.: CSF Total tau, Aβ42 and Phosphory-
lated tau Protein as Biomarkers for Alzheimer’s Disease. Molecular Neurobiology
24(1-3), 087–098 (2001)
7. Cates, J., Fletcher, P.T., Styner, M., Hazlett, H.C., Whitaker, R.: Particle-based
shape analysis of multi-object complexes. In: Medical image computing and
computer-assisted intervention (MICCAI). pp. 477–485 (2008)
10 S. Pölsterl et al.
8. Cheng, H.T., Ispir, M., Anil, R., Haque, Z., Hong, L., Jain, V., Liu, X., Shah,
H., et al.: Wide & Deep Learning for Recommender Systems. In: Proc. of the 1st
Workshop on Deep Learning for Recommender Systems (DLRS) (2016)
9. Chételat, G., Landeau, B., Eustache, F., Mézenge, F., Viader, F., de la Sayette,
V., Desgranges, B., Baron, J.C.: Using voxel-based morphometry to map the
structural changes associated with rapid conversion in MCI: a longitudinal MRI
study. NeuroImage 27, 934–946 (2005)
10. Cox, D.R.: Regression models and life tables (with discussion). Journal of the Royal
Statistical Society. Series B (Statistical Methodology) 34, 187–220 (1972)
11. Cuingnet, R., Gerardin, E., Tessieras, J., Auzias, G., Lehéricy, S., Habert, M.O.,
Chupin, M., Benali, H., et al.: Automatic classification of patients with Alzheimer’s
disease from structural MRI: a comparison of ten methods using the ADNI database.
NeuroImage 56, 766–781 (2011)
12. Da, X., Toledo, J.B., Zee, J., Wolk, D.A., Xie, S.X., Ou, Y., Shacklett, A., Parmpi,
P., et al.: Integration and relative value of biomarkers for prediction of MCI to AD
progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype
and CSF biomarkers. NeuroImage. Clinical 4, 164–173 (2014)
13. Desikan, R.S., Cabral, H.J., Fischl, B., Guttmann, C.R.G., Blacker, D., Hyman,
B.T., Albert, M.S., Killiany, R.J.: Temporoparietal MR imaging measures of atrophy
in subjects with mild cognitive impairment that predict subsequent diagnosis of
Alzheimer disease. American journal of neuroradiology 30, 532–538 (2009)
14. Desikan, R.S., Cabral, H.J., Settecase, F., Hess, C.P., Dillon, W.P., Glastonbury,
C.M., Weiner, M.W., Schmansky, N.J., et al.: Automated MRI measures predict
progression to Alzheimer’s disease. Neurobiology of aging 31, 1364–1374 (2010)
15. Devanand, D.P., Pradhaban, G., Liu, X., Khandji, A., Santi, S.D., Segal, S., Rusinek,
H., Pelton, G.H., et al.: Hippocampal and entorhinal atrophy in mild cognitive
impairment: Prediction of Alzheimer disease. Neurology 68(11), 828–836 (2007)
16. Faraggi, D., Simon, R.: A neural network model for survival data. Stat. Med. 14(1),
73–82 (1995)
17. Fischl, B.: FreeSurfer. NeuroImage 62(2), 774–781 (2012)
18. Frisoni, G.B., Ganzola, R., Canu, E., Rub, U., Pizzini, F.B., Alessandrini, F.,
Zoccatelli, G., Beltramello, A., Caltagirone, C., Thompson, P.M.: Mapping local
hippocampal changes in Alzheimer’s disease and normal ageing with MRI at 3
Tesla. Brain 131(12), 3266–3276 (2008)
19. Gerardin, E., Chételat, G., Chupin, M., Cuingnet, R., Desgranges, B., Kim, H.S.,
Niethammer, M., Dubois, B., Lehéricy, S., Garnero, L., Eustache, F., Colliot, O.,
Initiative, A.D.N.: Multidimensional classification of hippocampal shape features
discriminates alzheimer’s disease and mild cognitive impairment from normal aging.
NeuroImage 47, 1476–1486 (2009)
20. Gutiérrez-Becker, B., Wachinger, C.: Deep multi-structural shape analysis: ap-
plication to neuroanatomy. In: Medical image computing and computer-assisted
intervention (MICCAI). pp. 523–531 (2018)
21. Harrell, F.E., Califf, R.M., Pryor, D.B., Lee, K.L., Rosati, R.A.: Evaluating the
yield of medical tests. Journal of the American Medical Association 247, 2543–2546
(1982)
22. Hastie, T., Tibshirani, R., Friedman, J.: The Elements of Statistical Learning.
Springer, second edn. (2009)
23. Ioffe, S., Szegedy, C.: Batch Normalization: Accelerating Deep Network Training by
Reducing Internal Covariate Shift. In: Proc. of the 32nd International Conference
on Machine Learning. pp. 448–456 (2015)
Wide and Deep Neural Network for Survival Analysis 11
24. Jack, C.R., Bernstein, M.A., Fox, N.C., Thompson, P., Alexander, G., Harvey, D.,
Borowski, B., Britson, P.J., et al.: The Alzheimer’s disease neuroimaging initiative
(ADNI): MRI methods. Journal of Magnetic Resonance Imaging 27(4), 685–691
(2008)
25. Jack, C.R., Knopman, D.S., Jagust, W.J., Petersen, R.C., Weiner, M.W., Aisen,
P.S., Shaw, L.M., Vemuri, P., et al.: Tracking pathophysiological processes in
Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. The
Lancet Neurology 12(2), 207–216 (2013)
26. Katzman, J.L., Shaham, U., Bates, J., Cloninger, A., Jiang, T., Kluger, Y., Bates,
J., Jiang, T., Kluger, Y.: DeepSurv: personalized treatment recommender system
using a Cox proportional hazards deep neural network. BMC Med. Res. Methodol.
18(24) (2018)
27. Kauppi, K., Fan, C.C., McEvoy, L.K., Holland, D., Tan, C.H., Chen, C.H., An-
dreassen, O.A., Desikan, R.S., et al.: Combining Polygenic Hazard Score With
Volumetric MRI and Cognitive Measures Improves Prediction of Progression From
Mild Cognitive Impairment to Alzheimer’s Disease. Frontiers in Neuroscience 12
(2018)
28. Kingma, D.P., Ba, J.: Adam: A Method for Stochastic Optimization. In: 3rd Int.
Conf. on Learning Representations (ICLR) (2015)
29. Langa, K.M., Levine, D.A.: The diagnosis and management of mild cognitive
impairment: a clinical review. JAMA 312, 2551–2561 (2014)
30. Lee, G., Nho, K., Kang, B., Sohn, K.A., Kim, D., Alzheimer’s Disease Neuroimag-
ing Initiative: Predicting Alzheimer’s disease progression using multi-modal deep
learning approach. Scientific reports 9, 1952 (2019)
31. Li, K., O’Brien, R., Lutz, M., Luo, S., Alzheimer’s Disease Neuroimaging Initiative:
A prognostic model of Alzheimer’s disease relying on multiple longitudinal measures
and time-to-event data. Alzheimer’s & dementia : the journal of the Alzheimer’s
Association 14, 644–651 (2018)
32. Liaw, R., Liang, E., Nishihara, R., Moritz, P., Gonzalez, J.E., Stoica, I.: Tune: A
Research Platform for Distributed Model Selection and Training (2018)
33. Liestøl, K., Andersen, P.K., Andersen, U.: Survival analysis and neural nets. Stat.
Med. 13(12), 1189–1200 (1994)
34. Liu, K., Chen, K., Yao, L., Guo, X.: Prediction of Mild Cognitive Impairment
Conversion Using a Combination of Independent Component Analysis and the Cox
Model. Frontiers in human neuroscience 11, 33 (2017)
35. Liu, M., Zhang, J., Yap, P.T., Shen, D.: View-aligned hypergraph learning for
Alzheimer’s disease diagnosis with incomplete multi-modality data. Medical image
analysis 36, 123–134 (2017)
36. Liu, X., Chen, K., Wu, T., Weidman, D., Lure, F., Li, J.: Use of multimodality
imaging and artificial intelligence for diagnosis and prognosis of early stages of
Alzheimer’s disease. Translational research : the journal of laboratory and clinical
medicine 194, 56–67 (2018)
37. Lu, D., Popuri, K., Ding, G.W., Balachandar, R., Beg, M.F., Alzheimer’s Disease
Neuroimaging Initiative: Multimodal and Multiscale Deep Neural Networks for the
Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images.
Scientific reports 8, 5697 (2018)
38. McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R., Kawas,
C.H., Klunk, W.E., Koroshetz, W.J., et al.: The diagnosis of dementia due to
Alzheimer’s disease: recommendations from the National Institute on Aging-
Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.
12 S. Pölsterl et al.
Alzheimer’s & dementia : the journal of the Alzheimer’s Association 7(3), 263–9
(2011)
39. Minoshima, S., Giordani, B., Berent, S., Frey, K.A., Foster, N.L., Kuhl, D.E.:
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s
disease. Annals of Neurology 42(1), 85–94 (1997)
40. Moradi, E., Pepe, A., Gaser, C., Huttunen, H., Tohka, J.: Machine learning frame-
work for early MRI-based Alzheimer’s conversion prediction in MCI subjects.
NeuroImage 104, 398–412 (2015)
41. Petersen, R.C.: Mild Cognitive Impairment. New England Journal of Medicine
364(23), 2227–2234 (2011)
42. Pölsterl, S., Conjeti, S., Navab, N., Katouzian, A.: Survival analysis for high-
dimensional, heterogeneous medical data: Exploring feature extraction as an alter-
native to feature selection. Artificial intelligence in medicine 72, 1–11 (2016)
43. Qi, C.R., Su, H., Mo, K., Guibas, L.J.: PointNet: Deep Learning on Point Sets for
3D Classification and Segmentation. In: The IEEE Conference on Computer Vision
and Pattern Recognition (CVPR). pp. 652–660 (2017)
44. Scheltens, P., Blennow, K., Breteler, M.M.B., de Strooper, B., Frisoni, G.B., Sal-
loway, S., Van der Flier, W.M.: Alzheimer’s disease. The Lancet 388(10043), 505–517
(2016)
45. Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M.,
Iwatsubo, T., Jack, C.R., et al.: Toward defining the preclinical stages of Alzheimer’s
disease: recommendations from the National Institute on Aging-Alzheimer’s Associ-
ation workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s &
dementia : the journal of the Alzheimer’s Association 7(3), 280–92 (2011)
46. Teipel, S.J., Kurth, J., Krause, B., Grothe, M.J.: The relative importance of
imaging markers for the prediction of Alzheimer’s disease dementia in mild cognitive
impairment — Beyond classical regression. NeuroImage: Clinical 8, 583–593 (2015)
47. Thung, K.H., Adeli, E., Yap, P.T., Shen, D.: Stability-Weighted Matrix Completion
of Incomplete Multi-modal Data for Disease Diagnosis. Medical image computing
and computer-assisted intervention (MICCAI) pp. 88–96 (2016)
48. Tong, T., Gao, Q., Guerrero, R., Ledig, C., Chen, L., Rueckert, D., Alzheimer’s
Disease Neuroimaging Initiative: A Novel Grading Biomarker for the Prediction
of Conversion From Mild Cognitive Impairment to Alzheimer’s Disease. IEEE
transactions on bio-medical engineering 64, 155–165 (2017)
49. Vemuri, P., Weigand, S.D., Knopman, D.S., Kantarci, K., Boeve, B.F., Petersen,
R.C., Jack, C.R.: Time-to-event voxel-based techniques to assess regional atrophy
associated with MCI risk of progression to AD. NeuroImage 54, 985–991 (2011)
50. Wachinger, C., Reuter, M., Initiative, A.D.N., et al.: Domain adaptation for
Alzheimer’s disease diagnostics. Neuroimage 139, 470–479 (2016)
51. Wachinger, C., Salat, D.H., Weiner, M., Reuter, M., Initiative, A.D.N.: Whole-
brain analysis reveals increased neuroanatomical asymmetries in dementia for
hippocampus and amygdala. Brain 139(12), 3253–3266 (2016)
52. Zhang, D., Shen, D., Alzheimer’s Disease Neuroimaging Initiative: Multi-modal
multi-task learning for joint prediction of multiple regression and classification
variables in Alzheimer’s disease. NeuroImage 59, 895–907 (2012)
53. Zhou, H., Jiang, J., Lu, J., Wang, M., Zhang, H., and, C.Z.: Dual-Model Radiomic
Biomarkers Predict Development of Mild Cognitive Impairment Progression to
Alzheimer’s Disease. Frontiers in Neuroscience 12 (2019)
54. Zhou, T., Liu, M., Thung, K.H., Shen, D.: Latent Representation Learning for
Alzheimer’s Disease Diagnosis with Incomplete Multi-modality Neuroimaging and
Genetic Data. IEEE Transactions on Medical Imaging pp. 1–1 (2019)
